IJDDP/
Articles/
2504000158
  • Open Access
  • Review
Bacopa monnieri Extract As a Neuroprotective and Cognitive Enhancement Agent
  • Bevin J. Nishanth 1,   
  • Princy Vijayababu 2, *,   
  • Noble K. Kurian 3

Received: 14 Jul 2023 | Accepted: 14 Aug 2023 | Published: 27 Dec 2023

Abstract

Traditional Indian medicine uses the neuroprotective and cognitive-enhancing effects of the spice, Bacopa monnieri, commonly known as Brahmi. This paper provides an overview of the potential neuropharmacological benefits and therapeutic applications of Bacopa monnieri. Bacopa monnieri has therapeutic value due to the inclusion of bioactive compounds, including alkaloids, flavonoids, tannins, and phenolics. Bacoside A, a triterpenoid saponin of the Dammarane family, has been studied most because of its potential to improve memory and cognitive function. Specific brain regions that are affected by bacoside A experience an increase in protein and RNA production, oxidative stress protection, improved cerebral blood flow, and enhanced synaptic activity. By boosting antioxidant defense mechanisms, lowering oxidative stress, and altering neurotransmitter levels, Bacopa monnieri demonstrates neuroprotective effects. By blocking the activity of acetylcholinesterase, lowering the production of β-amyloid plaques, and modifying neurotransmitter levels, it has demonstrated potential for treating neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. As a natural neuroprotective and cognitive-improving agent, Bacopa monnieri is generally found to be promising. To completely comprehend its mechanisms of action and assess its long-term toxicity, more studies are necessary. Further research is needed to determine whether Bacopa monnieri can be used as a possible treatment for neurodegenerative diseases.

References 

  • 1.
    Subhose, V.; Srinivas, P.; Narayana, A. Basic principles of pharmaceutical science in Ayurvĕda. Bull. Indian Inst. Hist. Med. Hyderabad 2005, 35, 83‒92.
  • 2.
    Gohil, K.J.; Patel, J.A. A review on Bacopa monniera: current research and future prospects. Int. J. Green Pharm. 2010, 4, 1–9.
  • 3.
    Amin, H.; Sharm,a R. Nootropic efficacy of Satvavajaya Chikitsa and Ayurvedic drug therapy: A comparative clinical exposition. Int. J. Yoga. 2015, 8, 109‒116.
  • 4.
    Rajan, K.E.; Preethi, J.; Singh, H.K.; et al. Molecular and Functional Characterization of Bacopa monniera: A Retrospective Review. Evid. Based Complement. Alternat. Med. 2015, 2015, 945217.
  • 5.
    Barrett, S.C.H.; Strother, J.L. Taxonomy and natural history of Bacopa (Scrophulariaceae) in California. Systemat. Botany 1978, 408‒419.
  • 6.
    Bhandari, P.; Kumar, N.; Singh, B.; et al. Cucurbitacins from Bacopa monnieri. Phytochemistry 2007, 68, 1248‒5124.
  • 7.
    Mohapatra, H.P.; Rath, S.P. In vitro studies of Bacopa monnieri--an important medicinal plant with reference to its biochemical variations. Indian, J. Exp. Biol. 2005, 43, 373‒376.
  • 8.
    Bose, K.C.; Bose, N.K. Observations on the actions and uses of Herpestis monniera. J. Ind. Med. Assoc. 1931, 1, 60.
  • 9.
    Russo, A.; Borrelli, F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 2005, 12, 305‒317.
  • 10.
    Vishnupriya, P.; Padma, V.V. A review on the antioxidant and therapeutic potential of Bacopa monnieri. React. Oxygen Spec. 2017, 3, 111‒120.
  • 11.
    Elangovan, V.; Govindasamy, S.; Ramamoorthy, N.; et al. In vitro studies on the anticancer activity of Bacopa monnieri. Fitoterapia 1995, 66, 211‒215.
  • 12.
    Jasim, B.; Daya, P.S.; Sreelakshmi, K.S.; et al. Bacopaside N1 biosynthetic potential of endophytic Aspergillus sp. BmF 16 isolated from Bacopa monnieri. 3 Biotech. 2017, 7, 210.
  • 13.
    Saini, N.; Oelhafen, S.; Hua, H.; et al. Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways. Neurobiol. Dis. 2010, 40, 82‒92.
  • 14.
    Singh, H.K.; Rastogi, R.P.; Srimal, R.C.; et al. Effect of bacosides A and B on avoidance responses in rats. Phytother. Res. 1988, 2, 70‒75.
  • 15.
    Kamkaew, N.; Scholfield, C.N.; Ingkaninan, K.; et al. Bacopa monnieri and its constituents is hypotensive in anaesthetized rats and vasodilator in various artery types. J. Ethnopharmacol. 2011, 137, 790‒795.
  • 16.
    Kumar, S.S.; Saraswathi, P.; Vijayaraghavan, R. Effect of bacopa monniera on cold stress induced neurodegeneration in hippocampus of wistar rats: a histomorphometric study. J. Clin. Diagn. Res. 2015, 9, AF05‒AF07.
  • 17.
    Dhanasekaran, M.; Tharakan, B.; Holcomb, L.A.; et al. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother. Res. 2007, 21, 965‒969.
  • 18.
    Singh, H.K.; Dhawan, B.N. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Ind. J. Pharm. 1997, 29, 359.
  • 19.
    Charles, P.D.; Ambigapathy, G.; Geraldine, P.; et al. Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation. J. Ethnopharmacol. 2011, 134, 55‒61.
  • 20.
    Charoenphon, N.; Anandsongvit, N.; Kosai, P.; et al. Brahmi (Bacopa monnieri): Up-to-date of memory boosting medicinal plant: A review. Ind. J. Agri. Res. 2016, 50, 1‒7.
  • 21.
    Hou, C.C.; Lin, S.J.; Cheng, J.T.; et al. Bacopaside III, bacopasaponin G, and bacopasides A, B, and C from Bacopa monniera. J. Nat. Prod. 2002, 65, 1759‒1763.
  • 22.
    Chakravarty, A.K.; Garai, S.; Masuda, K.; et al. Bacopasides III-V: Three new triterpenoid glycosides from Bacopa monniera. Chem. Pharm. Bull. 2003, 51, 215‒217.
  • 23.
    Le, X.T.; Nguyet Pham, H.T.; Van Nguyen, T.; et al. Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism. J. Ethnopharmacol. 2015, 164, 37‒45.
  • 24.
    Jadiya, P.; Khan, A.; Sammi, S.R.; et al. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease. Biochem. Biophys. Res. Commun. 2011, 413, 605‒610.
  • 25.
    Piyabhan, P.; Wannasiri, S.; Naowaboot, J. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia. Clin. Exp. Pharmacol. Physiol. 2016, 43, 1234‒1242.
  • 26.
    Malishev, R.; Shaham-Niv, S.; Nandi, S.; et al. Bacoside-A, an Indian Traditional-Medicine Substance, Inhibits β-Amyloid Cytotoxicity, Fibrillation, and Membrane Interactions. ACS. Chem. Neurosci. 2017, 8, 884‒891.
  • 27.
    Joshi, H.; Parle, M. Brahmi rasayana improves learning and memory in mice. Evid. Based Complement. Alternat. Med. 2006, 3, 79‒85.
  • 28.
    Paulose, C.S.; Chathu, F.; Khan, S.R.; et al. Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression. Neurochem. Res. 2008, 33, 1663‒1671.
  • 29.
    Nobili, F.; Vitali, P.; Canfora, M.; et al. Effects of long-term Donepezil therapy on rCBF of Alzheimer’s patients. Clin. Neurophysiol. 2002, 113, 1241‒1248.
  • 30.
    Pandey, R.; Gupta, S.; Tandon, S.; et al. Baccoside A suppresses epileptic-like seizure/convulsion in Caenorhabditis elegans. Seizure 2010, 19, 439‒442.
  • 31.
    Le, X.T.; Pham, H.T.; Do, P.T.; et al. Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems. Neurochem. Res. 2013, 38, 2201‒2215.
  • 32.
    Kamkaew, N.; Norman Scholfield, C.; Ingkaninan, K.; et al. Bacopa monnieri increases cerebral blood flow in rat independent of blood pressure. Phytother. Res. 2013, 27, 135‒138.
  • 33.
    Dwivedi, S.; Nagarajan, R.; Hanif, K.; et al. Standardized Extract of Bacopa monniera Attenuates Okadaic Acid Induced Memory Dysfunction in Rats: Effect on Nrf2 Pathway. Evid. Based Complement. Alternat. Med. 2013, 2013, 294501.
  • 34.
    Malishev, R.; Nandi, S.; Kolusheva, S.; et al. Bacoside-A, an anti-amyloid natural substance, inhibits membrane disruption by the amyloidogenic determinant of prion protein through accelerating fibril formation. Biochim. Biophys. Acta 2016, 1858, 2208‒2214.
  • 35.
    Abdul Manap, A.S.; Vijayabalan, S.; Madhavan, P.; et al. Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies. Drug Target Insights 2019, 13, 1177392819866412.
  • 36.
    Swathi, G.; Rajendra, W. Protective role of Bacopa monnieri on induced Parkinson’s disease with particular reference to catecholamine system. Int. J. Pharm. Sci. 2014, 6, 379‒382.
  • 37.
    Singh, B.; Pandey, S.; Rumman, M.; et al. Neuroprotective effects of Bacopa monnieri in Parkinson’s disease model. Metab. Brain Dis. 2020, 35, 517‒525.
  • 38.
    Komali, E.; Venkataramaiah, C.; Rajendra, W. Antiepileptic potential of Bacopa monnieri in the rat brain during PTZ-induced epilepsy with reference to cholinergic system and ATPases. J. Tradit. Complement. Med. 2020, 11, 137‒143.
  • 39.
    Mathew, J.; Balakrishnan, S.; Antony, S.; et al. Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A. J. Biomed. Sci. 2012, 19, 25.
  • 40.
    Mathew, J.; Gangadharan, G.; Kuruvilla, K.P.; et al. Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri. Neurochem. Res. 2011, 36, 7‒16.
  • 41.
    Mathew, J.; Paul, J.; Nandhu, M.S.; et al. Bacopa monnieri and Bacoside-A for ameliorating epilepsy associated behavioral deficits. Fitoterapia 2010, 81, 315‒322.
  • 42.
    McEwen, B.S. Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression. Dialogues Clin. Neurosci. 2004, 6, 119‒133.
  • 43.
    Zheng, F.; Luo, Y.; Wang, H. Regulation of brain-derived neurotrophic factor-mediated transcription of the immediate early gene Arc by intracellular calcium and calmodulin. J. Neurosci. Res. 2009, 87, 380‒392.
  • 44.
    Sukumaran, N.P.; Amalraj, A.; Gopi, S. Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst - A review on its mechanistic aspects. Complement. Ther. Med. 2019, 44, 68‒82.
  • 45.
    Konar, A.; Shah, N.; Singh, R.; et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 2011, 6, e27265.
  • 46.
    Jeyasri, R.; Muthuramalingam, P.; Suba, V.; et al. Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach. Biomolecules 2020, 10, 536.
  • 47.
    Lorca, C.; Mulet, M.; Arévalo-Caro, C.; et al. Plant-derived nootropics and human cognition: A systematic review. Crit. Rev. Food Sci. Nutr. 2022, 1‒25.
  • 48.
    Fatima, U.; Roy, S.; Ahmad, S.; et al. Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications. Biomed. Pharmacother. 2022, 153, 113469.
  • 49.
    Vohora, S.B.; Khanna, T.; Athar, M.; et al. Analgesic activity of bacosine, a new triterpene isolated from Bacopa monnieri. Fitoterapia 1997, 68, 361-365.
  • 50.
    Bellah, S.F.; Firoj, A.; Rahman, A.A.; et al. Preliminary phytochemical, anti-bacterial, analgesic, anti-diarrhoeal and cytotoxic activity of methanolic extract of polyalthia suberosa leaves. Int. J. Pharm. Sci. Res. 2012, 3, 1322‒1326.
  • 51.
    Ghosh, T.; Maity, T.K.; Singh, J. Antihyperglycemic activity of bacosine, a triterpene from Bacopa monnieri, in alloxan-induced diabetic rats. Planta. Med. 2011, 77, 804‒808.
  • 52.
    Khan, R.; Krishnakumar, A.; Paulose, C.S. Decreased glutamate receptor binding and NMDA R1 gene expression in hippocampus of pilocarpine-induced epileptic rats: Neuroprotective role of Bacopa monnieri extract. Epilepsy Behav. 2008, 12, 54‒60.
  • 53.
    Kumar, E.P.; Elshurafa, A.A.; Elango, K.; et al. Cytotoxic and anti -tumour properties of ethanolic extract of bacopa monnieri (L) penn. Anc. Sci. Life 1998, 17, 228‒234.
  • 54.
    Sabina, E.P.; Baskaran, U.L.; Martin, S.J.; et al. Assessment of antidiabetic activity of the traditional indian ayurvedic formulation brahmi gritham in streptozotocin-induced diabetic rats. Int. J. Pharm. Pharm. Sci. 2014, 6, 11.
  • 55.
    Hazra, S.; Banerjee, R.; Das, B.K.; et al. Evaluation of antidepressant activity of Bacopa monnieri in rat: a study in animal model of depression. Drug Discov. 2012, 2, 8‒3.
  • 56.
    Sairam, K.; Dorababu, M.; Goel, R.K.; et al. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 2002, 9, 207‒211.
  • 57.
    Hossain, H.; Al-Mansur, A.; Akter, S.; et al. Evaluation of anti-inflammatory activity and total tannin content from the leaves of Bacopa monnieri (Linn.). Int. J. Pharm. Sci. Res. 2014, 5, 1246.
  • 58.
    Singh, V.; Jain, N.; Shri, R. Effect of abiotic factors on bacoside A content, acetylcholinesterase inhibitory and antioxidant activities of Bacopa monnieri (L.) Wettst. J. Applied Pharma. Sci. 2021, 11, 63‒70.
  • 59.
    Aguiar, S.; Borowski, T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013, 16, 313‒326.
  • 60.
    Simpson, T.; Pase, M.; Stough, C. Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain. Evid. Based Complement. Alternat. Med. 2015, 2015, 615384.
  • 61.
    Ghosh, S.; Khanam, R.; Acharya Chowdhury, A. The Evolving Roles of Bacopa monnieri as Potential Anti-Cancer Agent: A Review. Nutr. Cancer 2021, 73, 2166‒2176.
  • 62.
    Gupta, G.L.; Sharma, L. Bacopa monnieri abrogates alcohol abstinence-induced anxiety-like behavior by regulating biochemical and Gabra1, Gabra4, Gabra5 gene expression of GABAA receptor signaling pathway in rats. Biomed. Pharmacother. 2019, 111, 1417‒1428.
  • 63.
    Banerjee, S.; Anand, U.; Ghosh, S.; et al. Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders. Phytother. Res. 2021, 35, 5668‒5679.
  • 64.
    Konar, A.; Gautam, A.; Thakur, M.K. Bacopa monniera (CDRI-08) Upregulates the Expression of Neuronal and Glial Plasticity Markers in the Brain of Scopolamine Induced Amnesic Mice. Evid. Based Complement. Alternat. Med. 2015, 2015, 837012.
  • 65.
    Sabina, E.P.; Peter, S.J.; Prathap, S.; et al. A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats. J. Histotechnol. 2019, 42, 128‒136.
  • 66.
    Channa, S.; Dar, A.; Anjum, S.; et al. Atta-Ur-Rahman. Anti-inflammatory activity of Bacopa monniera in rodents. J. Ethnopharmacol. 2006, 104, 286‒289.
  • 67.
    Khan, A.V.; Ahmed, Q.U.; Shukla, I.; et al. Antibacterial efficacy of Bacopa monnieri leaf extracts against pathogenic bacteria. Asian Biomedicine 2010, 4, 651‒655.
  • 68.
    Fazlul, M.K.K.; Deepthi, S.P.; Irfan, M. Antibacterial and antifungal activity of various extracts of Bacopa monnieri. Int. J. Pharm. Res. 2019, 11, 1698–1702
  • 69.
    Prabhakar, S.; Saraf, M.K.; Pandhi, P.; et al. Bacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice. Psychopharmacology 2008, 200, 27‒37.
  • 70.
    Gudipati, T.; Srivastava, P.; Bhadauria, R.; et al. Hepatoprotective potential of in vitro Bacopa monnieri (L.) against carbon tetrachloride-induced hepatotoxicity in albino mice. Int. J. Pharm. Biologic. Sci. 2012, 3, 664‒672.
  • 71.
    Fatima, U.; Roy, S.; Ahmad, S.; et al. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Front. Nutr. 2022, 9, 972379.
  • 72.
    Bhattacharya, S.K.; Bhattacharya, A.; Kumar, A.; et al. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 2000, 14, 174‒179.
Share this article:
Download PDF
DOI
10.53941/ijddp.2023.100015
Issue
Volume 2, Issue 4
How to Cite
Nishanth, B. J.; Vijayababu, P.; Kurian, N. K. Bacopa monnieri Extract As a Neuroprotective and Cognitive Enhancement Agent. International Journal of Drug Discovery and Pharmacology 2023, 2 (4), 44–56. https://doi.org/10.53941/ijddp.2023.100015.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2023 by the authors.